BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38114526)

  • 21. Quantitative ultrasound radiomics using texture derivatives in prediction of treatment response to neo-adjuvant chemotherapy for locally advanced breast cancer.
    Dasgupta A; Brade S; Sannachi L; Quiaoit K; Fatima K; DiCenzo D; Osapoetra LO; Saifuddin M; Trudeau M; Gandhi S; Eisen A; Wright F; Look-Hong N; Sadeghi-Naini A; Tran WT; Curpen B; Czarnota GJ
    Oncotarget; 2020 Oct; 11(42):3782-3792. PubMed ID: 33144919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A priori prediction of tumour response to neoadjuvant chemotherapy in breast cancer patients using quantitative CT and machine learning.
    Moghadas-Dastjerdi H; Sha-E-Tallat HR; Sannachi L; Sadeghi-Naini A; Czarnota GJ
    Sci Rep; 2020 Jul; 10(1):10936. PubMed ID: 32616912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early Prediction of Breast Cancer Therapy Response using Multiresolution Fractal Analysis of DCE-MRI Parametric Maps.
    Machireddy A; Thibault G; Tudorica A; Afzal A; Mishal M; Kemmer K; Naik A; Troxell M; Goranson E; Oh K; Roy N; Jafarian N; Holtorf M; Huang W; Song X
    Tomography; 2019 Mar; 5(1):90-98. PubMed ID: 30854446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiomic analysis of DCE-MRI for prediction of response to neoadjuvant chemotherapy in breast cancer patients.
    Fan M; Wu G; Cheng H; Zhang J; Shao G; Li L
    Eur J Radiol; 2017 Sep; 94():140-147. PubMed ID: 28712700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative digital histopathology and machine learning to predict pathological complete response to chemotherapy in breast cancer patients using pre-treatment tumor biopsies.
    Saednia K; Lagree A; Alera MA; Fleshner L; Shiner A; Law E; Law B; Dodington DW; Lu FI; Tran WT; Sadeghi-Naini A
    Sci Rep; 2022 Jun; 12(1):9690. PubMed ID: 35690630
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Tadayyon H; Gangeh M; Sannachi L; Trudeau M; Pritchard K; Ghandi S; Eisen A; Look-Hong N; Holloway C; Wright F; Rakovitch E; Vesprini D; Tran WT; Curpen B; Czarnota G
    Oncotarget; 2019 Jun; 10(39):3910-3923. PubMed ID: 31231468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrasound-based deep learning radiomics in the assessment of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer.
    Jiang M; Li CL; Luo XM; Chuan ZR; Lv WZ; Li X; Cui XW; Dietrich CF
    Eur J Cancer; 2021 Apr; 147():95-105. PubMed ID: 33639324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer using radiomics of pretreatment dynamic contrast-enhanced MRI.
    Yoshida K; Kawashima H; Kannon T; Tajima A; Ohno N; Terada K; Takamatsu A; Adachi H; Ohno M; Miyati T; Ishikawa S; Ikeda H; Gabata T
    Magn Reson Imaging; 2022 Oct; 92():19-25. PubMed ID: 35636571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Texture analysis using machine learning-based 3-T magnetic resonance imaging for predicting recurrence in breast cancer patients treated with neoadjuvant chemotherapy.
    Eun NL; Kang D; Son EJ; Youk JH; Kim JA; Gweon HM
    Eur Radiol; 2021 Sep; 31(9):6916-6928. PubMed ID: 33693994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studying local tumour heterogeneity on MRI and FDG-PET/CT to predict response to neoadjuvant chemoradiotherapy in rectal cancer.
    Schurink NW; van Kranen SR; Berbee M; van Elmpt W; Bakers FCH; Roberti S; van Griethuysen JJM; Min LA; Lahaye MJ; Maas M; Beets GL; Beets-Tan RGH; Lambregts DMJ
    Eur Radiol; 2021 Sep; 31(9):7031-7038. PubMed ID: 33569624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MRI texture features from tumor core and margin in the prediction of response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
    Kolios C; Sannachi L; Dasgupta A; Suraweera H; DiCenzo D; Stanisz G; Sahgal A; Wright F; Look-Hong N; Curpen B; Sadeghi-Naini A; Trudeau M; Gandhi S; Kolios MC; Czarnota GJ
    Oncotarget; 2021 Jul; 12(14):1354-1365. PubMed ID: 34262646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring breast cancer response to neoadjuvant chemotherapy with ultrasound signal statistics and integrated backscatter.
    Piotrzkowska-Wróblewska H; Dobruch-Sobczak K; Klimonda Z; Karwat P; Roszkowska-Purska K; Gumowska M; Litniewski J
    PLoS One; 2019; 14(3):e0213749. PubMed ID: 30870478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Machine learning with magnetic resonance imaging for prediction of response to neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis.
    Liang X; Yu X; Gao T
    Eur J Radiol; 2022 May; 150():110247. PubMed ID: 35290910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Machine learning on MRI radiomic features: identification of molecular subtype alteration in breast cancer after neoadjuvant therapy.
    Liu HQ; Lin SY; Song YD; Mai SY; Yang YD; Chen K; Wu Z; Zhao HY
    Eur Radiol; 2023 Apr; 33(4):2965-2974. PubMed ID: 36418622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T
    Crombé A; Périer C; Kind M; De Senneville BD; Le Loarer F; Italiano A; Buy X; Saut O
    J Magn Reson Imaging; 2019 Aug; 50(2):497-510. PubMed ID: 30569552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic contrast-enhanced MRI texture analysis for pretreatment prediction of clinical and pathological response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
    Teruel JR; Heldahl MG; Goa PE; Pickles M; Lundgren S; Bathen TF; Gibbs P
    NMR Biomed; 2014 Aug; 27(8):887-96. PubMed ID: 24840393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A radiomic model to classify response to neoadjuvant chemotherapy in breast cancer.
    McAnena P; Moloney BM; Browne R; O'Halloran N; Walsh L; Walsh S; Sheppard D; Sweeney KJ; Kerin MJ; Lowery AJ
    BMC Med Imaging; 2022 Dec; 22(1):225. PubMed ID: 36564734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of axillary response by monitoring with ultrasound and MRI during and after neoadjuvant chemotherapy in breast cancer patients.
    Eun NL; Son EJ; Gweon HM; Kim JA; Youk JH
    Eur Radiol; 2020 Mar; 30(3):1460-1469. PubMed ID: 31802216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer.
    Li ZY; Wang XD; Li M; Liu XJ; Ye Z; Song B; Yuan F; Yuan Y; Xia CC; Zhang X; Li Q
    World J Gastroenterol; 2020 May; 26(19):2388-2402. PubMed ID: 32476800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast Cancer Treatment Response Monitoring Using Quantitative Ultrasound and Texture Analysis: Comparative Analysis of Analytical Models.
    Sannachi L; Gangeh M; Tadayyon H; Gandhi S; Wright FC; Slodkowska E; Curpen B; Sadeghi-Naini A; Tran W; Czarnota GJ
    Transl Oncol; 2019 Oct; 12(10):1271-1281. PubMed ID: 31325763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.